Insulin Pumps (External): Market Research Report

April 2018 | 205 pages | ID: IEBBE771102EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 15 companies including many key and niche players such as -

• Debiotech S.A.
• F. Hoffmann-La Roche, Ltd.
• Insulet Corp.
• Medtronic Plc.
• Sooil Development Co. Ltd.
• Tandem Diabetes Care Inc.

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Insulin Pumps: A Prelude
Key Benefits Offered Infuse Sustained Growth Opportunities
Developed Regions Underpin Sales Growth
The United States – The Largest Market
Europe – A Market with Vast Potential
Lower Current Penetration Leaves Significant Room for Growth

Table 1. Insulin Pumps Market by Region (2016): Percentage Breakdown of Number of Users for Established Markets and Rest of World (includes corresponding Graph/Chart)

Table 2. Insulin Pump Penetration Rate (as a % of Total Diabetics) in Type 1 Diabetic Patients by Country (2016) (includes corresponding Graph/Chart)

Rising Incidence of Diabetes – A Major Market Driving Factor

Table 3. Global Diabetic Population by Region (2015 & 2040) (includes corresponding Graph/Chart)

Table 4. Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2015 (includes corresponding Graph/Chart)

Table 5. Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2040 (includes corresponding Graph/Chart)

Diabetes – Assessing the Economic Burden

Table 6. Diabetes Related Healthcare Expenditure by Region: 2015 & 2040 (in US$ Billion) (includes corresponding Graph/Chart)

Table 7. Major Spenders on Diabetes (2015): Annual Expenditure on Diabetes Treatment and Management in US$ Billion for Ten Leading Countries (includes corresponding Graph/Chart)

2. COMPETITIVE ANALYSIS

Insulin Pumps Market – Set for Interesting Road Ahead

Table 8. Leading Players in the Global External Insulin Pumps Market (2016): Percentage Breakdown of Value Sales for Insulet, J&J (Animas), Medtronic, Roche, Tandem and Others (includes corresponding Graph/Chart)

Comparison of Select Durable Insulin Pumps by Manufacturer
Medtronic Banks on New Solutions and Distribution Expansion to Retain Dominance
Tandem Sees Gradual Rise in Market Share
Ypsomed Eyes Brighter Prospects with YpsoPump
Medtrum – A New Entrant with a Strong Product
Competitive Landscape in the Insulin Patch Pump Market
Insulet’s OmniPod Benefits from Lack of Close Competition in its League
Cellnovo’s Patch Pump Combines Functionality and Cost-Effectiveness
Valeritas’ V-Go – An Affordable Patch Pump for Type II Diabetics
Tough Ground for New Entrants

3. NOTEWORTHY MARKET TRENDS

Type II Diabetes – A Market with Significant Potential
Patch Pumps Gain Manufacturer Attention
Prefilled Insulin Cartridges Gain Popularity over Manual Filling
The Rise of Smart Pumps – A Major Game Changer
Innovative Features Spruce Up the Market for Insulin Pumps
Artificial Pancreas System (APS) – The Future of Diabetes Care
Artificial Pancreas – Are We There Yet?
The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps

Table 9. Percentage Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart)

Table 10. Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart)

Table 11. Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart)

Table 12. Life Expectancy for Select Countries in Number of Years: 2015 (includes corresponding Graph/Chart)

Alarming Rise in Obesity – A Business Case for Diabetes Care
Global Obesity Facts in a Nutshell

Table 13. Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart)

Table 14. Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart)

Diabetes in Developing Countries to Expand Opportunities

Table 15. Global External Insulin Pumps Market - Geographic Regions Ranked by % CAGR (Value Sales) for 2015-2022: Asia-Pacific, Latin America, US, Europe and Canada (includes corresponding Graph/Chart)

4. KEY MARKET DRIVERS AND CHALLENGES

ICR: A Key Factor to Success
Customer Satisfaction: Crucial to Stay Competitive
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
Undiagnosed Diabetes – A Key Challenge
Better Safety Review – A Growing Need for Insulin Pumps
Insulin Pump Training - Not Receiving Adequate Attention
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
Competition from Other Insulin Delivery Technologies Continues
Implantable Insulin Pumps – A Potential Threat to External Insulin Pumps
Lantus: A Threat to Insulin Pump Manufacturers

5. DIABETES & INSULIN – AN ABSTRACT

Diabetes - A Fatal Disease
Risk Factors for Diabetes
Types of Diabetes
Long Term Complications of Diabetes
Testing Sugar Levels: Easy and Accurate
Insulin
Pancreas: The Main Source of Insulin in Human Body
Types of Insulin
Types of Insulin & Onset of Action
Goal of Insulin Therapy
Insulin Delivery Systems
a. Syringes
b. Insulin Pens
c. Jet Injectors
d. Tablets
e. External Insulin Pumps
f. Artificial Pancreas
Insulin Delivery Technologies

6. PRODUCT OVERVIEW

7. PRODUCT INNOVATIONS/INTRODUCTIONS

Medtronic Rolls Out MiniMed 670G System
Tandem Unveils New Software Update for t:slim Insulin Pumps
Tandem Introduces t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
Tandem Launches t:lock Connector
Tandem Receives US Patent for Infusion Pump and Electronic Device Integration
SOOIL Development Unveils DANA Diabecare RS Insulin Pump
Cellnovo Files FDA 510(k) Clearance for Diabetes Management System
Medtronic Obtains FDA Nod for its New MiniMed 670G System
Medtrum Launches Medtrum P6 Tubeless Insulin Pump
Medtronic Launches MiniMed 630G System
Tandem Secures FDA Expanded Indication for t:slim Insulin Pump
EMA Clears Use of mylife YpsoPump with NovoRapid PumpCart
Animas Receives FDA Expanded Indication for Animas Vibe Insulin Pump in Children
Medtronic Introduces MiniMed Connect System for Insulin Pumps and CGMs
Tandem Gets FDA Nod for t:slim G4 Insulin Pump
Unilife Rolls Out Instant Patch Pumps Platform - Imperium
Medtronic Rolls Out MiniMed 640G System
Tandem Bags FDA Clearance for t:flex Insulin Pump

8. RECENT INDUSTRY ACTIVITY

Animas Decides to Exit Insulin Pump Business
Tandem to Commence At-Home Pivotal Trial for t:slim X2 Insulin Pump
Aspire Capital Fund to Invest in Valeritas Holdings
Roche Diabetes Care Discontinues Accu-Chek Brand in the US
Insulet to Distribute its Omnipod System in Europe
Valeritas Achieves Better Results with V-Go Device
Valeritas Shows Quality Results with V-Go Wearable Device
Medtronic Collaborates with Aetna
Roche to Acquire mySugr
Tandem Announces Order Intake for t:slim X2 Insulin Pump
Bigfoot Secure FDA’s Clearance for Artificial Pancreas Trial
Tandem Inks Technology Licensing Deal with TypeZero
Ypsomed and Novo Nordisk Sign Pact for mylife YpsoPump
UnitedHealth Group Selects Medtronic As Exclusive Supplier of Insulin Pumps
Cellnovo and Roche Enter into Commercial Agreement for BGM
Insulet Inks Deal with Mode for Licensing Artificial Pancreas Algorithm
Ypsomed Expands Availability of mylife OmniPod in Europe
Medtronic Enters into Agreement with Chengdu Government to Produce Insulin Pumps
Insulet and Eli Lilly Team Up to Develop New Version of OmniPod for Delivering Lilly's Humalog
Tandem and Dexcom Ink Deal to Pair their Devices
BD Medical and Medtronic Collaborate to Launch New Infusion Set
Bigfoot Biomedical Takes Over Asante Solutions
Debiotech to Take Over Rights to iSense CGM
Medtronic Acquires Covidien

9. FOCUS ON SELECT PLAYERS

Debiotech S. A. (Switzerland)
F. Hoffmann-La Roche, Ltd. (Switzerland)
Insulet Corp. (USA)
Medtronic Plc. (Ireland)
Sooil Development Co. Ltd. (Korea)
Tandem Diabetes Care Inc. (USA)
Valeritas Inc. (USA)
Ypsomed Holding AG (Switzerland)

10. GLOBAL MARKET PERSPECTIVE

Table 16. World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 17. World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 18. World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
The Prime Market for Insulin Pumps

Table 19. Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s)

Table 20. Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)

Table 21. Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart)

Table 22. Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart)

Table 23. US Market for Diabetes Management (2015 & 2018P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart)

Increasing Inclination towards Patch Pumps
Artificial Pancreas System (APS): The Future of Diabetes Management
Select Clinical Studies on Artificial Pancreas Technology
Competitive Scenario
Comparison of Select Insulin Pump Systems Available in the US
Reimbursements
Regulatory Scenario
FDA Announces a New Mandate for Manufacturing Companies
Product Approvals/Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 24. The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 25. The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current & Future Analysis
Diabetes Statistics

Table 26. Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart)

Table 27. Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart)

B. Market Analytics

Table 28. Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 29. Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. EUROPE

A. Market Analysis
Current & Future Analysis
Market Overview
Regional Scenario
Diabetes Prevalence in Europe

Table 30. Diabetes Prevalence in Europe (2015): Prevalence of Type I & Type II Diabetes As Percentage of Adult Population (Aged 20 to 79 Years) by Country (includes corresponding Graph/Chart)

Product Approval
B. Market Analytics

Table 31. European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 32. European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 33. European 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

3A. FRANCE

A. Market Analysis
Current & Future Analysis
Strategic Corporate Development
B. Market Analytics

Table 34. French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 35. French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3B. GERMANY

Market Analysis

Table 36. German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 37. German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3C. ITALY

Market Analysis

Table 38. Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 39. Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3D. THE UNITED KINGDOM

A. Market Analysis
Current & Future Analysis
Enhanced Focus on Diabetes Management Drives Demand
INPUT (The Insulin Pump Therapy Group)
NICE (National Institute of Clinical Excellence)
Product Launch
B. Market Analytics

Table 40. The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 41. The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3E. SPAIN

Market Analysis

Table 42. Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 43. Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3F. RUSSIA

Market Analysis

Table 44. Russian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 45. Russian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3G. REST OF EUROPE

A. Market Analysis
Current & Future Analysis
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 46. Rest of Europe Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 47. Rest of Europe Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

A. Market Analysis
Asia-Pacific: A Rapidly Growing Market

Table 48. Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart)

Table 49. Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Table 50. Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart)

Table 51. Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Review of Select Markets
China
Overview
China: An Untapped Goldmine
India
Diabetes Scenario
Insulin Pumps Market in India – An Overview
New Indigenously Developed Product Could be the Answer
Medtronic: The Current Market Leader
Diabetic Epidemic Spurs Indian Market
Strategic Corporate Development
Key Player
B. Market Analytics

Table 52. Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 53. Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. LATIN AMERICA

A. Market Analysis
Current & Future Analysis
Growing Population of Diabetics Spurs Demand

Table 54. Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart)

Table 55. Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

A Peek in to the Brazilian Insulin Pumps Market
B. Market Analytics

Table 56. Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 57. Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. REST OF WORLD

A. Market Analysis
Current & Future Analysis
Growing Prevalence of Diabetes: Key Market Driver

Table 58. African Diabetes and Population Statistics (2015 & 2040P) (includes corresponding Graph/Chart)

Table 59. Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Table 60. Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)

Table 61. Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

B. Market Analytics

Table 62. Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 63. Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 15 (including Divisions/Subsidiaries - 18)
The United States (11)
Europe (6)
  France (1)
  The United Kingdom (1)
  Rest of Europe (4)
Asia-Pacific (Excluding Japan) (1)